UCLA bioengineers and a team of researchers have developed smart insulin, called i-insulin, to prevent hypoglycemia in patients who take insulin to manage their blood sugar levels. Hypoglycemia is one of the diabetic complications characterized by a decrease in blood sugar to a potentially dangerous level. However, the researchers said it will have to undergo clinical trials.
One of the popular blood sugar drugs called canagliflozin, sold under the brand name Invokana, has been found to significantly reduce the risk of kidney failure in people with type 2 diabetes. Also, the drug has already been prescribed to protect cardiovascular health in type 2 diabetics.
Medical marijuana has been legalized in some states. In fact, last year, the FDA recognized a new drug for epilepsy made from marijuana, which means it can be used medically. But, what about using medical marijuana in patients with diabetes. Researchers are not sure whether diabetics can actually use medical marijuana.
A recent study shows the cost of insulin per patient with type 1 diabetes nearly doubled from 2012 to 2016, adding turmoil to the battle against increasing drug prices. According to the Health Care Cost Institute (HCCI), type 1 diabetics spent $2,864 per patient on insulin in 2012 and it increased to $5,705 per patient in 2016.